MD Anderson Automates Laboratory Workflow with Stone Bond Technologies' EE-LIMS™
News Jul 03, 2008
The newly established Small Interfering Ribonucleic Acid (siRNA) Facility at M. D. Anderson Cancer Center has been charged with providing high quality siRNA screening services for both internal and external customers.
M. D. Anderson has chosen Stone Bond Technologies’ EE-LIMS™ to document activities within the laboratory workflow at its siRNA facility, increasing throughput, while reducing the risk of errors, and providing automation for the management of operations in its siRNA Laboratory.
As one of the newest fields in the study of nucleic acids, small interfering RNA has shown considerable potential in laboratory studies to change how diseases are treated. Considering how difficult it is to work with these molecules and the specialized equipment devoted to their isolation and study, labs specializing in this area have a strong need to document the work that goes into producing genetic data that corresponds to the RNA in a given sample.
According to Stone Bond, its LIMS is an award winning Web-based laboratory information management system, recipient of the Bio-IT World magazine’s Grand Prize winner for technical innovation in its annual Best Practice awards, in the category of IT Infrastructure and Informatics.
Built on Stone Bond’s versatile Enterprise Enabler integration platform, EE-LIMS automates laboratory workflows, invoicing, data and sample tracking, collections and other business processes to help laboratories reduce overhead and administrative costs.
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
Largest Genetic Study of Osteoarthritis Advances ResearchNews
Osteoarthritis is a complex disease, and the genetic basis of the disease has proved difficult to pin down. A new study from the Sanger Institute provides much-needed hope.READ MORE
Comments | 0 ADD COMMENT
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
World Congress on Advances in Addiction Science and Medicine
Sep 24 - Sep 25, 2018